UA144506U - METHOD OF LOCAL TREATMENT OF CATARRHAL GINGIVITIS IN MEN EMPLOYED ON HARMFUL PRODUCTION - Google Patents

Abstract

The method of topical treatment of catarrhal gingivitis in men working in hazardous industries is the use of topical drugs. Apply applications of ointment "Bepanten" on the cap, made of silicone impression material "Dentaflex solid" (1 time per day for 2 hours), for 14 days and mouth baths with mineral water "Novozbruchanska" at the beginning and after the shift for 14 days.

Description

A useful model relates to medicine, namely dentistry, and can be used to treat periodontal diseases, particularly catarrhal gingivitis.

A known method of treatment of periodontal diseases (|1| "Method of treatment of chronic catarrhal gingivitis", which includes the local application of a plant antiseptic with the simultaneous appointment of antibiotic therapy, probiotics and osteotropic therapy.

However, the known method does not sufficiently affect the specific immune resistance of the oral cavity of patients, and the use of antibiotics in periodontal diseases is not always justified by the final result, taking into account the side effects of antibiotics, such as immunosuppression.

The useful model is based on the task of improving the well-known method, by using "Bepanten" ointment and "Novozbruchanska" oral baths with mineral water, which is aimed at eliminating inflammatory processes in periodontal tissues and restoring local immune protection in patients, achieving an increase in the effectiveness of gingivitis treatment and avoiding possible complications of treatment, and therefore increasing clinical effectiveness in general and achieving long-term remission.

The task is solved by the well-known method of treating periodontal diseases, which consists in the use of a local therapy drug, which differs in that Bepanten ointment is applied topically as a dropper once a day for 2 hours for a course of 14 days and oral baths with mineral water "Novozbruchanska " at the beginning and at the end of the work shift within 14 days.

The active substance of the drug Bepanten - dexpanthenol (provitamin B5) - is actively adsorbed by skin cells. Upon entering epithelial cells, dexpanthenol is transformed, forming pantothenic acid. It is actually vitamin B5 (pantothenic acid) that determines the effect of Bepanten. Pantothenic acid is a more common component of coenzyme A and takes an active part in acetylation processes, acetylcholine synthesis, stimulates the regeneration of skin and mucous membranes, normalizes cell metabolism, accelerates mitosis, and increases the strength of collagen fibers. Bepanten is quickly absorbed and transformed in the body, replenishing endogenous reserves of pantothenic acid. It has a regenerating, moisturizing and weak anti-inflammatory effect on the skin and mucous membrane.

The method is carried out as follows: after professional teeth cleaning and training

For hygiene reasons, Bepanten ointment is applied topically to patients once a day for 2 hours for a course of 14 days.

Example

Patient B. complained of bleeding gums while brushing his teeth and eating. On examination: the face is symmetrical, the submandibular lymph nodes are not enlarged, the gingival papillae are hyperemic, swollen, they bleed when touched with a probe, there are dental layers on the gums.

Hygienic index according to Fedorov-Volodkina 1.7 points, KPI 2.5 points, RMA according to Ragta 25 95, test

Schiller-Pysareva is sharply positive.

Diagnosis: chronic catarrhal gingivitis.

Treatment: after removal of dental layers with the help of an ultrasonic scaler, correction of poor-quality fillings, training in the rules of oral care, the patient is given Bepanten ointment on a mouthpiece 1 time a day for 2 hours for a course of 14 days and mouth baths with "Novozbruchanska" mineral water at the beginning and at the end after the end of the work shift within 14 days.

After the treatment on the 14th day, the patient has no complaints, the gums are pale pink in color, there is no bleeding gums, GI according to Fedorov-Volodkina 1.5-1.8 points, KPI 0.2-0.3 points, RMA according to

Ragta 12 95, Schiller-Pysarev test is negative.

After 1 month: the patient has no complaints, the gum papillae are not hyperemic, GI according to Fedorov-

Volodkina 1.2-1.5 points, KPI 0.2 points, RMA for Ragta 15 95, Shiler-Pysarev test is negative.

A stable clinical effect indicates a state of remission.

There are no complaints 6 months after the treatment. During an objective examination of the phenomena, it was not established that it was inflamed. Clinical observation data do not differ from those obtained directly after treatment. A stable clinical effect indicates a state of remission.

30 people with periodontal disease were treated using the proposed method. Patients of the comparison group with catarrhal gingivitis (30 people) were treated with a preparation based on sodium hypochloride (Table Mo 2).

As can be seen from Table No. 1, during treatment, indicators of the cellular and humoral link of local immune protection in persons treated by the proposed method return to normal. (510)

Table 1

Changes in laboratory parameters during periodontal treatment 31.0751.7" 27.950.87 27.50.3

IDAv g/l 155,753.77 140.5:2-1.87 133,320.4

Note: 7 - statistically significant (p«0.05) difference between the indicators of patients compared before and after treatment

Table 2

Changes in laboratory parameters during periodontal treatment 32.6x2.3" 31.71.5 27.50.3

IDAv g/l 160,452.87 153,252.67 133,320.4

Note: 7 - statistically significant (p<0.05) difference between the indicators of patients compared before and after treatment

Thus, the proposed method of treatment of periodontal diseases, in particular catarrhal gingivitis, is easy to perform, reduces the number of visits for catarrhal gingivitis to 2, prevents complications in the near and distant periods of observation, promotes stable remission of periodontal diseases.

Sources of information: 1. Pat. OA 28573, IPC AbE1K 6/00. Method of treatment of chronic catarrhal gingivitis/ T.M.

Moshel, A.K. Nikolishin - No. 200709854. Application 09/03/2007. Publ. 10.12.2007, Bull. Mo. 11. 2. Pat. KO2283100, IPC AbIK 31/165; AbIK 36/06: AbIK 36/736; Ab1R 1/02. A method of periodontal treatment/ L.E. Leonova, V.F. Kolomoytsev, S.A. Tretynykh, A.Yu. Cherepanov, E.Yu. Omigova - MO 2005119223/14. Application 21.06.2005. Publ. 10.09.2006. 3. Patent SHA 88985, IPC AbIK 31/00 AbЭ1Р1/02 Means for the treatment of periodontal disease and mucous membrane of the oral cavity with anesthesin in the form of a dental medicinal film (I.S.

Hrynovets, T.G. Kalynok, A.V. Fogged) - Mo 201312196. Announced on October 18, 2013.

Published on 04/10/2014. Bulletin "Industrial Property" Mo. 1-4 pp. 4. Patent SHA 89824 MPK Ab1K 31/00 Phytoremedial in the form of a gel for the prevention and treatment of periodontal diseases (T.N. Pavlyuk, M.M. Rozhko). - Mo 201315421. Announced on 12/30/2013.

Published on April 25, 2014. Bulletin "Industrial Property" Mo. 8-3 p.

Claims (1)

FORMULA OF A USEFUL MODEL A method of local treatment of catarrhal gingivitis in men working in a hazardous industry, which consists in the use of local therapy preparations, which differs in that applying applications of "Bepanten" ointment on a mouthpiece made of silicone impression material "Oepiayeh zoiia" (1 time per day for 2 hours) for 14 days and oral baths with "Novozbruchanska" mineral water at the beginning and after the end of the work shift for 14 days.